Description
The debate noted dramatic regional variation in GPR32 expression but didn’t resolve functional consequences or toxicity risks. This gap prevents prediction of therapeutic windows and adverse effects.
Source: Debate session sess_SDA-2026-04-01-gap-014 (Analysis: SDA-2026-04-01-gap-014)